225 related articles for article (PubMed ID: 33392303)
21. Differential gut microbiota composition between type 2 diabetes mellitus patients and healthy controls: A systematic review.
Umirah F; Neoh CF; Ramasamy K; Lim SM
Diabetes Res Clin Pract; 2021 Mar; 173():108689. PubMed ID: 33549678
[TBL] [Abstract][Full Text] [Related]
22. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
23. Metformin and Colorectal Cancer - A Systematic Review.
Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
Wong SH; Yu J
Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
[TBL] [Abstract][Full Text] [Related]
25. Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis.
Ma W; Chen J; Meng Y; Yang J; Cui Q; Zhou Y
Front Microbiol; 2018; 9():1336. PubMed ID: 29988362
[TBL] [Abstract][Full Text] [Related]
26. Alterations of gut microbiome in patients with type 2 diabetes mellitus who had undergone cholecystectomy.
Wei B; Wang Y; Xiang S; Jiang Y; Chen R; Hu N
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E113-E121. PubMed ID: 33166187
[TBL] [Abstract][Full Text] [Related]
27. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
He XK; Su TT; Si JM; Sun LM
Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
[TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
Caesar R
Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
[TBL] [Abstract][Full Text] [Related]
30. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
Brunkwall L; Orho-Melander M
Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
[TBL] [Abstract][Full Text] [Related]
31. Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway.
Xu X; Lv J; Guo F; Li J; Jia Y; Jiang D; Wang N; Zhang C; Kong L; Liu Y; Zhang Y; Lv J; Li Z
Front Microbiol; 2020; 11():814. PubMed ID: 32425919
[TBL] [Abstract][Full Text] [Related]
32. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
[TBL] [Abstract][Full Text] [Related]
33. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
[TBL] [Abstract][Full Text] [Related]
34. Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation.
de Kort S; Masclee AAM; Sanduleanu S; Weijenberg MP; van Herk-Sukel MPP; Oldenhof NJJ; van den Bergh JPW; Haak HR; Janssen-Heijnen ML
Sci Rep; 2017 Apr; 7():46527. PubMed ID: 28436468
[TBL] [Abstract][Full Text] [Related]
35. Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice.
Kattar SA; Jurjus R; Pinon A; Leger DY; Jurjus A; Boukarim C; Diab-Assaf M; Liagre B
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664279
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota and probiotics: Focus on diabetes mellitus.
Bordalo Tonucci L; Dos Santos KM; De Luces Fortes Ferreira CL; Ribeiro SM; De Oliveira LL; Martino HS
Crit Rev Food Sci Nutr; 2017 Jul; 57(11):2296-2309. PubMed ID: 26499995
[TBL] [Abstract][Full Text] [Related]
37. Biodiversity and richness shifts of mucosa-associated gut microbiota with progression of colorectal cancer.
Pan HW; Du LT; Li W; Yang YM; Zhang Y; Wang CX
Res Microbiol; 2020; 171(3-4):107-114. PubMed ID: 31982498
[TBL] [Abstract][Full Text] [Related]
38. Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma.
Powell MK; Cempirkova D; Dundr P; Grimmichova T; Trebicky F; E Brown R; Gregorova J; Litschmannova M; Janurova K; Pesta M; Heneberg P
Transl Oncol; 2020 Feb; 13(2):383-392. PubMed ID: 31896527
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota disorders cause type 2 diabetes mellitus and homeostatic disturbances in gut-related metabolism in Japanese subjects.
Adachi K; Sugiyama T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Funaki Y; Ogasawara N; Goto C; Sasaki M; Kasugai K
J Clin Biochem Nutr; 2019 May; 64(3):231-238. PubMed ID: 31138957
[TBL] [Abstract][Full Text] [Related]
40. Gut Microbiota and Colorectal Cancer.
Yu YN; Fang JY
Gastrointest Tumors; 2015 May; 2(1):26-32. PubMed ID: 26674881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
